Home
About
Overview
Sharing Data
ORCID
Help
History (33)
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
Ribose
Provider education to promote implementation of clinical practice guidelines.
Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy.
Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer.
See All 33 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer.
MacGilvary N, Cantor SB. Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer. DNA Repair (Amst). 2024 Dec; 144:103775.
View in:
PubMed
subject areas
Animals
BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
DNA Damage
DNA Repair
DNA Replication
Female
Humans
Neoplasms
Ovarian Neoplasms
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerase Inhibitors
authors with profiles
Sharon B Cantor PhD